Streptococcus salivarius BLIS K12™ was the very first probiotic strain developed for oral health. It’s backed by over 20 years of science, 100+ research studies, 20+ clinical trials, and 220 million+ doses consumed globally.
BLIS K12™ advanced oral probiotic strain:
Each lozenge contains:
Isomalt, Tableting Aids, Streptococcus salivarius K12 (contains at least 2.5 billion cfu/dose), Natural Flavour.
Take 1 lozenge 1-2 times a day, ideally after brushing teeth.
BLIS K12™, an oral probiotic strain of Streptococcus salivarius, plays a crucial role in maintaining a healthy balance in the oral and upper respiratory microbiome. It specifically colonizes the mouth and throat, where it helps prevent the overgrowth of harmful bacteria associated with throat infections and upper respiratory issues. BLIS K12™ produces powerful antimicrobial peptides called BLIS (Bacteriocin-Like Inhibitory Substances), which can inhibit the growth of pathogens like Streptococcus pyogenes, a common cause of strep throat. By establishing a protective barrier in the throat, BLIS K12™ may reduce the frequency and severity of sore throats, tonsillitis, and other upper respiratory tract infections. Additionally, its presence can support overall immune function in the upper respiratory system, potentially leading to improved resistance against various throat and respiratory ailments.
Get in touch to discuss further options for customizing your product.
Get in touch to discuss Minimum Orders Quantities (MOQs) and Pricing for this product.
Global Key Account Manager ENQUIRE NOW
